Moreover, the programmed cell death protein 1 (PD1)/programmed cell death ligand 1 (PD-L1) pathway has a low response rate of approximately 30% in inhibiting lung cancer, as characterized by the minimal cytotoxic T cell infiltration [13–15]. The gene discussed is CD274; the disease is lung carcinoma.